Page 8 - Investigator Global Assessment News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Soligenix Announces Top-line Results of the Phase 2a Study of SGX302 (Synthetic Hypericin) in Patients with Mild-to-Moderate Psoriasis

Clinical Success Achieved in Second Cohort of Patients PRINCETON, N.J., Jan. 4, 2024 /PRNewswire/ Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and.

Richard straubeChristopherj schaberPrnewswire soligenix incDrug administrationWorld health organizationUs congressOur public health solutionsDefense threat reduction agencyUs developmentBiomedical advanced researchDevelopment authorityEuropean medicines agencyNational institute of allergySoligenix incExchange commissionClinical success achieved

Argenx Reports Topline Results From ADDRESS Study Of Efgartigimod SC In Pemphigus

Argenx Reports Topline Results From ADDRESS Study Of Efgartigimod SC In Pemphigus
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomNoord hollandBen petokLuc truyenImmunology innovation programInside informationChief medical officerInvestigator global assessmentArea indexAbuse regulation

argenx Reports Topline Results from ADDRESS Study of Efgartigimod SC in Pemphigus

argenx Reports Topline Results from ADDRESS Study of Efgartigimod SC in Pemphigus
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Noord hollandUnited statesUnited kingdomBen petokLuc truyenImmunology innovation programExchange commissionReports topline resultsChief medical officerInvestigator global assessmentArea indexAbuse regulation

Dermata Enrolls First Patient in Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne

Dermata Enrolls First Patient in Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoChristopher nardoSean proehlDevelopment officerBusiness developmentDermata therapeutics incSpongilla treatment for acne researchExchange commissionDermata therapeuticsAcne researchChief developmentInvestigator global assessmentPrivate securities litigation reform act

Dermata Enrolls First Patient in Pivotal DMT310 Phase 3 STAR-1 Clinical

Dermata Enrolls First Patient in Pivotal DMT310 Phase 3 STAR-1 Clinical .

United statesSan diegoChristopher nardoDermata therapeutics incSpongilla treatment for acne researchNews networkDevelopment officerDermata therapeuticsAcne researchChief developmentTrial designInvestigator global assessmentAcne vulgarisLooking statements